Switch to
View more

Zenotech Laboratories Ltd

ZENOTECH
Health CareBiotechnology
SmallcapWith a market cap of ₹342 cr, stock is ranked 1,451
High RiskStock is 3.40x as volatile as Nifty
57.000.80 (+1.42%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹342 cr, stock is ranked 1,451
High RiskStock is 3.40x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
15.47
PB RatioPB Ratio
7.09
Dividend YieldDiv. Yield
Sector PESector PE
34.89
Sector PBSector PB
4.47
Sector Div YldSctr Div Yld
0.90%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves therapy areas, such as oncology and anesthesiology.

Financial TrendFinancial statements 

201920202021202217.7433.5622.8637.19-3.1310.78-1.2122.17
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings